David Hallinan
VP Regulatory Affairs
Cancer
OBI Pharma
Taiwan
Biography
Dr. Hallinan has over 25 years of operational and regulatory affairs experience across a range of therapeutic areas. Prior to joining OBI, David was VP Regulatory Affairs at Idenix Pharmaceuticals, and VP Regulatory Affairs and Quality Assurance at Parexel International. He holds a Ph.D. in Pharmacology and a B.Sc. in Biochemistry from University College, Dublin, Ireland.
Research Interest
Regulatory affairs
